Nanomedicine’s transformative impact on anti-diabetic drug discovery: an appraisal

被引:0
作者
Kunika Saini
Smriti Sharma
机构
[1] Miranda House,Computational Chemistry Research Laboratory, Department of Chemistry
[2] University of Delhi,undefined
来源
Journal of Nanoparticle Research | 2023年 / 25卷
关键词
Nanotechnology; Diabetes; Nanomedicine; Anti-diabetic drugs; Nanoparticles; Diagnostics; Therapeutics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide
    Candeias, Emanuel Monteiro
    Sebastiao, Ines Carolina
    Cardoso, Susana Maria
    Correia, Sonia Catarina
    Carvalho, Cristina Isabel
    Placido, Ana Isabel
    Santos, Maria Sancha
    Oliveira, Catarina Resende
    Moreira, Paula Isabel
    Duarte, Ana Isabel
    WORLD JOURNAL OF DIABETES, 2015, 6 (06) : 807 - 827
  • [22] An adenovirus-derived protein: A novel candidate for anti-diabetic drug development
    Hegde, Vijay
    Na, Ha-Na
    Dubuisson, Olga
    Burke, Susan J.
    Collier, J. Jason
    Burk, David
    Mendoza, Tamra
    Dhurandhar, Nikhil V.
    BIOCHIMIE, 2016, 121 : 140 - 150
  • [23] Insight into the drug delivery efficacy and anti-diabetic potential of cyclodextrin against hyperglycemia
    Sharmah, Bhaben
    Das, Joydeep
    Manna, Prasenjit
    INORGANIC CHEMISTRY COMMUNICATIONS, 2024, 161
  • [24] Anti-diabetic drug use and reduced risk of Parkinson's disease: A community-based cohort study
    Rozani, Violetta
    Bezimianski, Miri Glikshtein
    Azuri, Joseph
    Bitan, Michal
    Peretz, Chava
    PARKINSONISM & RELATED DISORDERS, 2024, 128
  • [25] ROLE OF ANTI-DIABETIC DRUGS AS THERAPEUTIC AGENTS IN ALZHEIMER'S DISEASE
    Rizvi, Syed Mohd. Danish
    Shaikh, Sibhghatulla
    Waseem, Shah Mohammad Abbas
    Shakil, Shazi
    Abuzenadah, Adel M.
    Biswas, Deboshree
    Tabrez, Shams
    Ashraf, Ghulam Md.
    Kamal, Mohammad Amjad
    EXCLI JOURNAL, 2015, 14 : 684 - 696
  • [26] The Impact of Natural and Synthetic Polymers in Formulating Micro and Nanoparticles for Anti-Diabetic Drugs
    Al-Hashimi, Nihad
    Babenko, Mai
    Saaed, Maria
    Kargar, Negeen
    ElShaer, Amr
    CURRENT DRUG DELIVERY, 2021, 18 (03) : 271 - 288
  • [27] The causal relationship between anti-diabetic drugs and gastrointestinal disorders: a drug-targeted mendelian randomization study
    Ju, Mingyan
    Deng, Tingting
    Jia, Xuemin
    Gong, Menglin
    Li, Yuying
    Liu, Fanjie
    Yin, Ying
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01)
  • [28] Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
    Artis, Dean R.
    Lin, Jack J.
    Zhang, Chao
    Wang, Weiru
    Mehra, Upasana
    Perreault, Mylene
    Erbe, David
    Krupka, Heike I.
    England, Bruce P.
    Arnold, James
    Plotnikov, Alexander N.
    Marimuthu, Adhirai
    Nguyen, Hoa
    Will, Sarah
    Signaevsky, Maxime
    Kral, John
    Cantwell, John
    Settachatgull, Calvin
    Yan, Douglas S.
    Fong, Daniel
    Oh, Angela
    Shi, Shenghua
    Womack, Patrick
    Powell, Benjamin
    Habets, Gaston
    West, Brian L.
    Zhang, Kam Y. J.
    Milburn, Michael V.
    Vlasuk, George P.
    Hirth, K. Peter
    Nolop, Keith
    Bollag, Gideon
    Ibrahim, Prabha N.
    Tobin, James F.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (01) : 262 - 267
  • [29] An efficient and effective ensemble of support vector machines for anti-diabetic drug failure prediction
    Kang, Seokho
    Kang, Pilsung
    Ko, Taehoon
    Cho, Sungzoon
    Rhee, Su-jin
    Yu, Kyung-Sang
    EXPERT SYSTEMS WITH APPLICATIONS, 2015, 42 (09) : 4265 - 4273
  • [30] Fast dissolving electrospun polymeric films of anti-diabetic drug repaglinide: formulation and evaluation
    Thakkar, Shreya
    More, Namdev
    Sharma, Dilip
    Kapusetti, Govinda
    Kalia, Kiran
    Misra, Manju
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (12) : 1921 - 1930